Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug552 | Best supportive care" which includes antivirals /antibiotics/ hydroxychloroquine; oxygen therapy Wiki | 1.00 |
| drug346 | Arm exercise electrocardiographic stress test Wiki | 1.00 |
| drug4079 | Treadmill electrocardiographic stress test Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D013577 | Syndrome NIH | 0.09 |
| D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.08 |
| D055371 | Acute Lung Injury NIH | 0.08 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Randomized, Parallel Group, Active Controlled Trial
Description: 1-month mortality is defined as the ratio of patients who will live after 1 month from study start out of those registered at baseline
Measure: One-month mortality rate between the two arms Time: One-monthDescription: Baseline, during treatment, One month
Measure: Biomarkers (IL-6, TNF-a, IL1, IL17, etc…) Time: One MonthDescription: Baseline, during treatment (Before every dose and 12 h post dose) up to 1 month
Measure: Lymphocyte count Time: One MonthDescription: Baseline, during treatment (Before every dose and 12 h post dose) up to 1 month
Measure: CRP (C-reactive protein) level Time: One MonthDescription: Baseline, during treatment (Before every dose and 12 h post dose) up to 1 month
Measure: PaO2 (partial pressure of oxygen) / FiO2 (fraction of inspired oxygen, FiO2) ratio (or P/F ratio) Time: One MonthDescription: At baseline, after seven days and if clinically indicated (up to 1 month)
Measure: Radiological response Time: one monthDescription: from baseline up to patients discharge (up to 1 month)
Measure: Duration of hospitalization Time: One MonthDescription: up to 1 month
Measure: Remission of respiratory symptoms Time: One MonthAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports